Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-CLL1 specific single-chain chimeric antigen receptors (scCARs) for cancer immunotherapy

Anti-CLL1 specific single-chain chimeric antigen receptors (scCARs) for cancer immunotherapy

US Patent 11014989 · Granted May 25, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Ipilimumab variants with enhanced specificity for binding at low pH2025
Polymer nanoparticle compositions for in vivo expression of polypeptides2025
Method of treatment using anti-CD19 rituximab-resistant chimeric antigen recepto2025
Protease-activating CD45-gate CAR2025
Targeted gene insertion for improved immune cells therapy2025
Targeted gene insertion for improved immune cells therapy2025
Targeted gene insertion for improved immune cells therapy2025
Method for improving production of car T cells2025
Method for improving production of car T cells2025
Chimeric antigen receptors targeting FLT32025
Method for generating t-cells compatible for allogenic transplantation2025
Targeted gene integration of CRS inhibitor genes for improved immune cells thera2025